Polygon Response to the Orange Belgium Financial E...
Mandatory Disclosure: Belgium Requires Large Compa...
Belgian DPA Finds Broad Tax Information Transfers ...
Top financial analysis software for advisors and R...
Belgian bank KBC expands into crypto trading
What ELTIFs’ recent developments mean for th...
Belgian authorities widen crackdown on corruption,...
Some of Belgium’s Best Breweries Are Coming ...

Celyad Oncology Provides Outlook for 2022

Published on: Sunday 09 January 2022

Celyad Oncology SA (Euronext & Nasdaq: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T ...

News source: https://uk.finance.yahoo.com/news/celyad-oncology-provides-outlook-2022-060100170.html

Share this news on: Facebook Twitter

RELATED NEWS

» Nyxoah Provides General Corporate Update

» Celyad Oncology Provides Outlook for 2022

» Brussels’ farmland grab angers the rest of Belgium

HEADLINE NEWS

» Belgium Says Dutch Found Tainted Eggs Back in November
» Belgium Cabinet Approves Draft Bill on Various Financial Provisions to Combat Tax Fraud
» Belgium Withdraws Closure of Cultural Venues After Artists Protest
» Growing Fixed-Rate Loans Could Shrink Protection in European Covered Bonds
» Beverages start-up Lahori gets $15 mn from Belgian fund Verlinvest
» BUX shifts into crypto investing
» Brussels’ farmland grab angers the rest of Belgium
» Efteling discriminated against Belgian woman and son on grounds of race and disability
» Maire Tecnimont awarded EPC contract for new aniline plant in Belgium
» Former Schroders real estate head Owen joins Immobel

My Financial News from Walloon Brabant, Belgium

Celyad Oncology Provides Outlook for 2022